Loading stock data...

Supriya Lifescience Limited

NSE: SUPRIYA BSE: SUPRIYA

NSE
746.00 0.70 (0.09%)

Prev Close

745.30002

Open Price

747

Volume

103,737

Today Low / High

742.15 / 755.05

52 WK Low / High

556.15 / 842

Range

709 - 783

BSE
745.00 0.10 (0.01%)

Prev Close

744.9

Open Price

758.25

Volume

1,430

Today Low / High

742.9 / 758.25

52 WK Low / High

556.85 / 841.7

Range

708 - 782

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 746 (target range: 709 - 783), reflecting a change of 0.69998 (0.09391863%). On the BSE, it is listed at 745 (target range: 708 - 782), showing a change of 0.1 (0.01342462%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

05 Dec 747.00 -0.24%
04 Dec 744.95 0.05%
03 Dec 743.00 0.75%
02 Dec 742.70 0.46%
01 Dec 751.15 -0.58%
30 Nov 751.15 -0.58%
28 Nov 761.75 -1.87%
27 Nov 772.00 -1.33%
26 Nov 757.60 1.31%
25 Nov 745.10 1.52%
24 Nov 744.80 0.15%
21 Nov 771.95 -3.74%
19 Nov 806.80 -5.05%
18 Nov 787.00 1.99%
17 Nov 789.70 -0.30%
14 Nov 785.00 0.60%
13 Nov 774.95 1.52%
12 Nov 745.60 2.25%
11 Nov 760.95 -2.31%
10 Nov 789.20 -4.19%

Supriya Lifescience Limited Graph

Supriya Lifescience Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Supriya Lifescience Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 746.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 745.00 752.45 677.21 - 827.70
759.90 607.92 - 911.88
767.35 537.15 - 997.56
Bearish Scenario 745.00 737.55 663.80 - 811.31
730.10 584.08 - 876.12
722.65 505.86 - 939.45

Overview of Supriya Lifescience Limited

ISIN

INE07RO01027

Industry

Biotechnology

Vol.Avg

297,863

Market Cap

60,040,168,800

Last Dividend

1

Official Website

Visit Website

IPO Date

2021-12-28

DCF Diff

900.64

DCF

-155

Financial Ratios Every Investor Needs

Stock Dividend of SUPRIYA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-04 September 04, 25 1 1 2025-09-05 2025-10-24
2024-09-20 September 20, 24 0.8 0.8 2024-09-20 2024-10-27
2023-09-15 September 15, 23 0.6 0.6 2023-09-15 2023-10-29
2022-09-01 September 01, 22 0.6 0.6 2022-09-02 2022-10-16

Stock Rating Details for SUPRIYA

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 5 Strong Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 696.49 Cr 312.14 Cr 384.35 Cr 0.5518 0.00 Cr 80.52 Cr 240.35 Cr 187.96 Cr 23.35 270.61 Cr 0.2699
2024-03-31 570.34 Cr 360.86 Cr 280.25 Cr 0.4914 6.69 Cr 23.19 Cr 157.17 Cr 119.11 Cr 14.80 183.58 Cr 0.2088
2023-03-31 451.02 Cr 180.81 Cr 280.13 Cr 0.6211 5.40 Cr 19.23 Cr 115.32 Cr 89.86 Cr 11.16 136.98 Cr 0.1992
2022-03-31 519.37 Cr 229.89 Cr 289.49 Cr 0.5574 1.66 Cr 13.73 Cr 202.16 Cr 151.81 Cr 18.86 221.56 Cr 0.2923
2021-03-31 385.37 Cr 151.17 Cr 234.20 Cr 0.6077 0.66 Cr 10.52 Cr 164.44 Cr 123.59 Cr 16.89 176.99 Cr 0.3207

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 76.06 Cr 1,112.31 Cr 115.56 Cr 996.7600 Cr 5.38 Cr -73.77 Cr 118.35 Cr 599.49 Cr 0.00 Cr 0.00 Cr 63.24 Cr 82.1620 Cr
2024-03-31 68.17 Cr 921.24 Cr 105.87 Cr 815.3660 Cr 5.49 Cr -62.68 Cr 85.25 Cr 457.30 Cr 14.87 Cr 0.00 Cr 63.80 Cr 76.8940 Cr
2023-03-31 85.25 Cr 820.28 Cr 120.82 Cr 699.4590 Cr 22.47 Cr -62.78 Cr 115.77 Cr 328.06 Cr 1.66 Cr 0.00 Cr 25.30 Cr 95.7800 Cr
2022-03-31 165.78 Cr 734.76 Cr 119.08 Cr 615.6880 Cr 27.42 Cr -138.36 Cr 92.31 Cr 231.67 Cr 25.45 Cr 2.93 Cr 0.05 Cr 99.6990 Cr
2021-03-31 31.07 Cr 445.82 Cr 176.88 Cr 268.9420 Cr 72.19 Cr 41.12 Cr 72.48 Cr 175.92 Cr 17.60 Cr 20.79 Cr 0.05 Cr 146.0190 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 172.5650 Cr -161.8200 Cr -6.5470 Cr 10.1890 Cr 4.1980 Cr 79.1540 Cr -162.3760 Cr 187.9580 Cr -0.1080 Cr -6.4390 Cr -33.1000 Cr
2024-03-31 113.3070 Cr -173.5750 Cr -22.3590 Cr -32.3480 Cr -82.6260 Cr 74.9560 Cr -145.6550 Cr 119.1140 Cr -16.6250 Cr -4.8290 Cr 30.5210 Cr
2023-03-31 66.1870 Cr -133.1450 Cr -9.7770 Cr -42.2130 Cr -70.3260 Cr 157.5820 Cr -108.4000 Cr 123.4870 Cr -4.6700 Cr -4.8290 Cr -23.4580 Cr
2022-03-31 48.8010 Cr -59.8220 Cr 149.6520 Cr -11.1030 Cr 138.6310 Cr 227.9080 Cr -59.9040 Cr 207.2450 Cr -0.7630 Cr -4.3910 Cr -19.8320 Cr
2021-03-31 75.8890 Cr -46.8010 Cr -14.5160 Cr 31.6890 Cr 14.5720 Cr 92.2930 Cr -48.2410 Cr 167.3930 Cr -11.6660 Cr -3.9560 Cr -23.0220 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 145.07 Cr 31.77 Cr 113.30 Cr 0.7810 45.25 Cr 34.79 Cr 4.32 54.38 Cr 0.2398
2025-03-31 184.11 Cr 81.88 Cr 102.23 Cr 0.5552 61.50 Cr 50.38 Cr 6.26 70.56 Cr 0.2737
2024-12-31 185.65 Cr 61.78 Cr 123.87 Cr 0.6672 60.99 Cr 46.78 Cr 5.82 68.05 Cr 0.2520
2024-09-30 166.10 Cr 70.40 Cr 95.70 Cr 0.5761 59.97 Cr 46.15 Cr 5.71 67.24 Cr 0.2778
2024-06-30 160.63 Cr 73.34 Cr 87.29 Cr 0.5434 57.89 Cr 44.64 Cr 5.55 64.77 Cr 0.2779

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 79.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -996.76 Cr
2025-03-31 79.15 Cr 0.00 Cr 79.15 Cr 134.36 Cr 118.35 Cr 437.04 Cr 599.49 Cr 1,112.31 Cr 115.56 Cr
2024-12-31 0.00 Cr 0.00 Cr 84.31 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -905.89 Cr
2024-09-30 77.51 Cr 9.46 Cr 86.96 Cr 105.73 Cr 107.99 Cr 413.36 Cr 522.68 Cr 1,012.39 Cr 106.50 Cr
2024-06-30 74.96 Cr 0.00 Cr 74.96 Cr 0.00 Cr 0.00 Cr 74.96 Cr 0.00 Cr 0.00 Cr -815.37 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 34.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 50.38 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 46.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 46.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 44.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹392.05 ₹523,416,543,448.00 ₹4,217,316.00
Anthem Biosciences Ltd. ANTHEM ₹654.00 ₹367,292,973,354.00 ₹172,953.00
Syngene International Limited SYNGENE ₹636.20 ₹255,571,660,670.00 ₹433,951.00
Piramal Pharma Limited PPLPHARMA ₹179.99 ₹238,138,841,929.00 ₹2,246,077.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,687.00 ₹193,204,039,392.00 ₹197,165.00
Concord Biotech Limited CONCORDBIO ₹1,409.00 ₹147,404,231,436.00 ₹51,263.00
Jubilant Ingrevia Limited JUBLINGREA ₹685.00 ₹108,211,381,700.00 ₹87,235.00
Blue Jet Healthcare Limited BLUEJET ₹546.85 ₹94,859,567,661.00 ₹181,910.00
Supriya Lifescience Limited SUPRIYA ₹746.00 ₹60,040,168,800.00 ₹103,737.00
Zota Health Care Limited ZOTA ₹1,579.50 ₹47,910,428,573.00 ₹22,133.00
Dishman Carbogen Amcis Limited DCAL ₹222.75 ₹34,923,434,411.00 ₹154,314.00

Key Executives

Managing Director
Dr. Saloni Satish Wagh

Gender: Not Specified

Year Born: 1990

Company Secretary & Compliance Officer
Ms. Prachi Suhas Sathe

Gender: female

Year Born:

Whole Time Director
Mr. Balasaheb Gulabrao Sawant

Gender: male

Year Born: 1964

Chief Financial Officer
Mr. Krishna Raghunathan

Gender: male

Year Born:

Joint Managing Director
Ms. Shivani Satish Wagh

Gender: female

Year Born: 1991

President of Business Development Strategy & Head of Formulations
Dr. Shekhar Bhaskar Bhirud

Gender: Not Specified

Year Born:

Founder, Executive Chairman & Whole Time Director
Dr. Satish Waman Wagh

Gender: Not Specified

Year Born: 1955

Chief Scientific Officer
Dr. Sushanta Kumar Gouranga Mishra

Gender: Not Specified

Year Born:

Technical Head
Dr. Shireesh Bhalchandra Ambhaikar

Gender: Not Specified

Year Born:

Whole-time Director
Ms. Smita Satish Wagh

Gender: female

Year Born: 1958

FAQs about Supriya Lifescience Limited

Who is the CEO of the company?

The CEO is Satish Waman Wagh.

What is the current market price of the stock?

The current price is ₹746.00.

What is the 52-week price range?

The range is ₹556.15-842.

What is the market capitalization of the company?

The market capitalization is ₹6,004.02 crores.

What is the dividend yield?

The dividend yield is 0.13%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 33.73.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Supriya Lifescience Limited (ISIN: INE07RO01027) is a leading Biotechnology in India. With a market capitalization of ₹6,004.02 crores and an average daily volume of 297,863 shares, it operates in the Biotechnology. The company last declared a dividend of ₹1.